Diagnostic Biochips, Inc. has officially entered a new phase with its first commercial instruments now in production and testing.

Diagnostic Biochips is giving neuroscientists the keys to unlock the brain and conduct groundbreaking electrophysiology research in order to find cures for the world’s most challenging neurological diseases, including Parkinson’s, Epilepsy, and others. The company’s patented core technologies, a microfabricated implantable neurosensor and data analysis software, allow researchers to collect high fidelity brain data with unprecedented spatiotemporal resolution. Research featuring DBC probes has been published in numerous peer-reviewed journals, and its devices are being used by hundreds of customers worldwide at the leading academic, government, and commercial research organizations.

Founded 2012